doi: 10.1158/1535-7163.MCT-10-0811
Most findings for both MOTS-c and 5-Amino-1MQ come from animal models (primarily mice)
[73,74] Other peptides derived from histone proteins have shown similar effects and have been investigated as therapeutic candidates in SLE, [75, 76, 77] including the phosphorylated spliceosomal epitope peptide P140, which represses B cell differentiation and protects against murine lupus
Used to successfully treat more than 1 million patients worldwide
Decreases appetite and reduces cravings Promotes weight loss 2-4 Lowers A1C levels (a marker of blood sugar control) Improves cardiometabolic health measures Enhances insulin sensitivity 1-3 The medication is not insulin
Summary BPC 157 Peptide Capsules have shown significant potential value in patients with digestive system diseases, especially having unique advantages in the treatment of gastric ulcers, IBD and leaky gut syndrome